Active Ingredient:

Each 5 ml of oral syrup contains: Sodium valproate 288.2 mg eq to Valproic acid 250 mg


  • Xoplict is indicated as monotherapy and adjunctive therapy in the treatment of patients with complex partial seizures that occur either in isolation or in association with other types of seizures.

  • Xoplict is indicated for use as sole and adjunctive therapy in the treatment of simple and complex absence seizures, and adjunctively in a patient with multiple seizures types which include absence seizures.

  • A simple absence seizure is defined as a very brief clouding of sensorium or loss of consciousness accompanied by certain generalized epileptic discharge without other detectable clinical signs. Complex absence seizure is the term used when other signs are also present.

Educational Materials: